STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

I-Mab (NASDAQ: IMAB), a US-based global biotech company specializing in precision immuno-oncology treatments for cancer, has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The conference is scheduled to take place from April 7-10, 2025.

The company's management team will be present at this virtual healthcare event, which serves as a significant platform for biotechnology companies to showcase their developments and connect with industry stakeholders.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-3.94% News Effect

On the day this news was published, IMAB declined 3.94%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB), a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in 24th Annual Needham Virtual Healthcare Conference, being held April 7-10, 2025.

Details are as follows:

24th Annual Needham Virtual Healthcare Conference 
Conference Date:April 7-10, 2025
Format:Company Presentation and one-on-one meetings
Presentation Time:Monday, April 7, 2025, 8:45 to 9:25 AM ET
Webcast Link:Register here
  

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit us at: https://www.i-mabbiopharma.com/ and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
PJ Kelleher
LifeSci Advisors
+1 617-430-7579
pkelleher@lifesciadvisors.com
IR@imabbio.com


FAQ

When is I-Mab (IMAB) presenting at the Needham Healthcare Conference 2025?

I-Mab will present at the 24th Annual Needham Virtual Healthcare Conference taking place from April 7-10, 2025.

What type of company is I-Mab (IMAB) and what is their focus?

I-Mab is a US-based global biotech company focused on developing precision immuno-oncology agents for cancer treatment.

Is the Needham Healthcare Conference 2025 virtual or in-person?

The 24th Annual Needham Healthcare Conference is being held virtually.

Which stock exchange is I-Mab (IMAB) listed on?

I-Mab (IMAB) is listed on the NASDAQ stock exchange.
I-Mab

NASDAQ:IMAB

IMAB Rankings

IMAB Latest News

IMAB Latest SEC Filings

IMAB Stock Data

533.68M
78.65M
21.43%
20%
2.43%
Biotechnology
Healthcare
Link
United States
Rockville